title: Editorial commentary: ACL tissue bioengineering clinical application is in its infancy.
abstract: Preclinical ACL tissue engineering studies show promise using a combination of cells, scaffolds, growth factors, and "stimulation," such as ultrasound or shockwave therapy, but clinical application is in its infancy. Bioactive scaffolds may be weak at time zero. A solution could be to add to the combination of cells, scaffolds, growth factors, simulation, and a structural tie.
authors.forename: James H
authors.initials: JH
authors.lastname: Lubowitz
mesh_terms: D006801:Humans; D007719:Knee Joint / Q000601:surgery*; D008023:Ligaments, Articular / Q000601:surgery*; D023822:Tissue Engineering / Q000379:methods*